InflaRx N.V (IFRX) concluded trading on Wednesday at a closing price of $0.80, with 0.39 million shares of worth about $0.31 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.19% during that period and on June 18, 2025 the price saw a gain of about 3.65%. Currently the company’s common shares owned by public are about 67.75M shares, out of which, 62.81M shares are available for trading.
Stock saw a price change of -4.19% in past 5 days and over the past one month there was a price change of -54.92%. Year-to-date (YTD), IFRX shares are showing a performance of -67.69% which decreased to -48.85% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.71 but also hit the highest price of $2.82 during that period. The average intraday trading volume for InflaRx N.V shares is 483.59K. The stock is currently trading -21.13% below its 20-day simple moving average (SMA20), while that difference is down -36.06% for SMA50 and it goes to -52.45% lower than SMA200.
InflaRx N.V (NASDAQ: IFRX) currently have 67.75M outstanding shares and institutions hold larger chunk of about 26.11% of that.
The stock has a current market capitalization of $53.57M and its 3Y-monthly beta is at 1.32. It has posted earnings per share of -$1.05 in the same period. It has Quick Ratio of 4.86 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IFRX, volatility over the week remained 2.51% while standing at 21.14% over the month.
Analysts are in expectations that InflaRx N.V (IFRX) stock would likely to be making an EPS of -0.2 in the current quarter, while forecast for next quarter EPS is -0.15 and it is -0.6 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.21 which is -0.19 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.24 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 18.14% while it is estimated to decrease by -0.44% in next year. EPS is likely to shrink at an annualized rate of 5.73% for next 5-years, compared to annual growth of 18.08% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on May 29, 2025 offering an Outperform rating for the stock and assigned a target price of $2 to it. Coverage by Cantor Fitzgerald stated InflaRx N.V (IFRX) stock as an Overweight in their note to investors on April 29, 2025, suggesting a price target of $10 for the stock. Stock get a Strong buy rating from Raymond James on October 28, 2021.
